Meta-analysis of Targeted Therapies in EGFR-mutated Non–Small Cell Lung Cancer

2024-9-11

Assessing the Impact of Multidisciplinary Cancer Consultations on Cancer Quality Metrics

2024-9-9

Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer

2024-9-9

Maintenance Therapy in Acute Myeloid Leukemia

2024-9-6

Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?

2024-9-3

Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy

2024-8-23

Proceedings of the American Radium Society® 106th Annual Meeting

2024-8-21

The Cost of Progression-Free Survival in Treating Low-Grade Glioma

2024-8-15

Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy

2024-8-1

Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients

2024-7-26

Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer

2024-7-16

Accuracy of Medical Oncology Prognosis for Metastatic Cancer Patients Evaluated for Enrollment Onto an Ongoing Randomized Clinical Trial

2024-7-12

Effect of Subgroups on Study Outcomes in Unresectable Hepatocellular Carcinoma Undergoing Upfront Systemic Treatment

2024-7-9

Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer

2024-7-8

Surgical Margins After Neoadjuvant Radiation for Locally Advanced Vulvar Carcinoma

2024-7-8

Concurrent use of Radiotherapy and Ribociclib

2024-7-4

Case Study on Analysing the Early Disease Detection of Pancreatic Ductal Adenocarcinoma in Korean Association for Clinical Oncology

2024-7-4

Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

2024-7-4

Inspiring the Next Generation

2024-7-4

Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer

2024-7-2

Why Basic Science Education Matters in Radiation Oncology

2024-7-1

Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients

2024-6-28

Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas

2024-6-28

Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival—Insights From a Systematic Review

2024-6-27

Modifiable Lifestyle Risk Factors in Adult Survivors of Childhood Cancer

2024-6-24

Hypofractionated Radiation Therapy

2024-6-21

Optimization Strategies in CAR T-cell Therapy

2024-6-21

Efficacy of Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

2024-6-21

Bevacizumab Combination Therapy Versus Standard Chemotherapy for Ovarian Cancer in Shorter and Longer Follow-Up Duration

2024-6-21

Institution-level Patterns of Care for Early-stage Oropharynx Cancers in the United States

2024-6-20

Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer

2024-6-20

Wilms’ Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5

2024-6-20

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

2024-5-27

Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma

2024-5-20

Meta-Analysis of 5-Fraction Preoperative Radiotherapy for Soft Tissue Sarcoma

2024-5-20

Multidisciplinary Educational Program to Standardize Education and Management of Immune-related Adverse Events

2024-5-17

Success of Ultra-low Dose Radiation Therapy for Primary Cutaneous B-cell Lymphoma

2024-5-17

Racial Disparities in Endometrial Cancer Clinical Trial Representation

2024-5-3

The microRNA-34 Family and Its Functional Role in Lung Cancer

2024-5-3

An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation

2024-4-26

Fulfilling the Role of a Parent While Undergoing Treatment for Cancer

2024-4-23

How Did We Get Here? The Progression From Frame-Based to Frameless Intracranial Stereotactic Radiosurgery

2024-4-23

Clinicopathological Characteristics, Survival and Prognostic Factors in Gastrointestinal Large Cell Neuroendocrine Carcinoma

2024-4-17

Magnetic Resonance Imaging Images Based Brain Tumor Extraction, Segmentation and Detection Using Convolutional Neural Network and VGC 16 Model

2024-4-16

Patterns of Treatment Failure in Primary Central Nervous System Lymphoma

2024-4-10

Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease

2024-4-9

Sentinel Node Navigation Surgery for Early Gastric Cancer

2024-4-8

First-line Immunotherapy for Metastatic Merkel Cell Carcinoma

2024-4-8

Radiation Proctitis in Patients With Locally Advanced Cervical Cancer Treated by Chemoradiation

2024-4-1

Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy

2024-3-15